Description: Avicanna Inc is a Canada-based company engaged in alternative medicine sector. The Company invests in its product discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. Its two main business segments are R&D and cultivation. The R&D business is primarily conducted out of Canada hhere scientific team develops products and engages the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto. The cultivation business controls two companies located in Santa Marta, Colombia that are authorized to cultivate and process cannabis for the production of Extracts, including Cannabidiol (CBD) and Tetrahydrocannabinol (THC).
Home Page: www.avicanna.com
AVCN Technical Analysis
480 University Avenue
Toronto,
ON
M5G 1V2
Canada
Phone:
647 243 5283
Officers
| Name | Title |
|---|---|
| Mr. Aras Azadian B.Econ, Mba | Co-Founder, CEO & Director |
| Dr. Frantz Le Devedec | Exec. VP of R&D |
| Mr. Roland Alvarez | SVP of Technical Operations |
| Ms. Ivana Maric | Exec. VP of Marketing |
| Dr. Carlos Enrique Maldonado Muete | SVP of Clinical Devel. |
| Ms. Caitlin Johnston | Sr. VP of Strategic Partnerships & Patient Access |
Exchange: TO
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 9.8389 |
| Price-to-Sales TTM: | 6.1399 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 124 |